{"id":423352,"date":"2024-10-20T06:46:02","date_gmt":"2024-10-20T06:46:02","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-iso-183622016a12022\/"},"modified":"2024-10-26T12:41:51","modified_gmt":"2024-10-26T12:41:51","slug":"bs-iso-183622016a12022","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-iso-183622016a12022\/","title":{"rendered":"BS ISO 18362:2016+A1:2022"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
2<\/td>\n | National foreword <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | 1 Scope 2 Normative references <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 4 \uea01General 5 Process definition 5.1 General <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | 5.2 Risk management 5.2.1 General considerations <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 5.2.2 Cell-based starting material risk assessment 5.2.3 CBHP process risk assessment <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 6 Manufacturing environment 6.1 General 6.2 Alternative processes <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | 6.3 Manufacturing environment design 6.3.1 Containment area 6.3.2 Construction containment features 6.4 Layout 6.5 Material and personnel flow 6.5.1 General <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | 6.5.2 Equipment 6.5.3 Handling of waste material 6.6 HVAC system 6.7 Utility services and ancillary equipment 6.8 Environmental and personnel monitoring programmes 7 Equipment 7.1 General <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 7.2 Additional requirements 8 Personnel 8.1 General 8.2 Personnel procedures 8.3 Gowning procedures 8.4 General employee health <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 9 Manufacture of product 9.1 General 9.2 Control of starting material 9.2.1 Cell-based starting material 9.2.2 Other starting materials <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 9.3 Manufacturing procedures 9.4 In-process controls and process monitoring 9.5 Virus elimination and inactivation 10 Process simulation and process confirmation 10.1 General <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 10.2 Process simulation 10.3 Process confirmation studies 10.4 Media selection and growth support <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 11 Finished product release: test for sterility 11.1 General 11.2 Additional requirements <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 12 Finished product release: testing for biological contamination that cannot be detected by the test for sterility 12.1 General 12.2 Extrinsic biological contamination 12.3 Intrinsic biological contamination <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | Annex A (informative) Examples of microbial risks for CBHP <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | Annex B (normative) Decision trees for application of risk assessment for cell-based starting materials <\/td>\n<\/tr>\n | ||||||
28<\/td>\n | Annex C (informative) Containment facilities <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | Annex D (normative) CBHP starting material <\/td>\n<\/tr>\n | ||||||
37<\/td>\n | Annex E (normative) Containment requirements for procured, non-sterile starting materials before entering the manufacturing area <\/td>\n<\/tr>\n | ||||||
38<\/td>\n | Annex F (informative) Typical elements of a process definition <\/td>\n<\/tr>\n | ||||||
39<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Manufacture of cell-based health care products. Control of microbial risks during processing<\/b><\/p>\n |